Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alternate Day Fasting Combined With Exercise for the Treatment of Non-alcoholic Fatty Liver Disease (NAFLD)

NCT04004403 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT04004403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04004403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alternate Day Fasting Combined With Exercise for the Treatment of Non-alcoholic Fatty Liver Disease (NAFLD)
Lead sponsor
University of Illinois at Chicago
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2019
Completion date
May 1, 2024
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic fatty liver disease, obesity